|
1
|
Meyers PA, Schwartz CL, Krailo M, et al:
Osteosarcoma: a randomized, prospective trial of the addition of
ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and
high-dose methotrexate. J Clin Oncol. 23:2004–2011. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bacci G, Forni C, Longhi A, et al: Local
recurrence and local control of non-metastatic osteosarcoma of the
extremities: a 27-year experience in a single institution. J Surg
Oncol. 96:118–123. 2007.PubMed/NCBI
|
|
3
|
Jawad MU, Cheung MC, Clarke J, et al:
Osteosarcoma: improvement in survival limited to high-grade
patients only. J Cancer Res Clin Oncol. 137:597–607. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mialou V, Philip T, Kalifa C, et al:
Metastatic osteosarcoma at diagnosis: prognostic factors and
long-term outcome - the French pediatric experience. Cancer.
104:1100–1109. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hegyi M, Semsei AF, Jakab Z, et al: Good
prognosis of localized osteosarcoma in young patients treated with
limb-salvage surgery and chemotherapy. Pediatr Blood Cancer.
57:415–422. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Stokkel MP, Linthorst MF, Borm JJ, et al:
A reassessment of bone scintigraphy and commonly tested
pretreatment biochemical parameters in newly diagnosed
osteosarcoma. J Cancer Res Clin Oncol. 128:393–399. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yeh CS, Wang JY, Cheng TL, et al: Fatty
acid metabolism pathway play an important role in carcinogenesis of
human colorectal cancers by microarray-bioinformatics analysis.
Cancer Lett. 233:297–308. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hess D and Igal RA: Genistein
downregulates de novo lipid synthesis and impairs cell
proliferation in human lung cancer cells. Exp Biol Med (Maywood).
236:707–713. 2011.PubMed/NCBI
|
|
9
|
Alo PL, Amini M, Piro F, et al:
Immunohistochemical expression and prognostic significance of fatty
acid synthase in pancreatic carcinoma. Anticancer Res.
27:2523–2527. 2007.PubMed/NCBI
|
|
10
|
Walter K, Hong SM, Nyhan S, et al: Serum
fatty acid synthase as a marker of pancreatic neoplasia. Cancer
Epidemiol Biomarkers Prev. 18:2380–2385. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Okawa Y, Hideshima T, Ikeda H, et al:
Fatty acid synthase is a novel therapeutic target in multiple
myeloma. Br J Haematol. 141:659–671. 2008. View Article : Google Scholar
|
|
12
|
Migita T, Ruiz S, Fornari A, et al: Fatty
acid synthase: a metabolic enzyme and candidate oncogene in
prostate cancer. J Natl Cancer Inst. 101:519–532. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Silva SD, Cunha IW, Younes RN, et al: ErbB
receptors and fatty acid synthase expression in aggressive head and
neck squamous cell carcinomas. Oral Dis. 16:774–780. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Orita H, Coulter J, Tully E, et al:
Inhibiting fatty acid synthase for chemoprevention of chemically
induced lung tumors. Clin Cancer Res. 14:2458–2464. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Saati GE and Archer MC: Inhibition of
fatty acid synthase and Sp1 expression by 3,3′-diindolylmethane in
human breast cancer cells. Nutr Cancer. 63:790–794. 2011.
|
|
16
|
Notarnicola M, Pisanti S, Tutino V, et al:
Effects of olive oil polyphenols on fatty acid synthase gene
expression and activity in human colorectal cancer cells. Genes
Nutr. 6:63–69. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Notarnicola M, Messa C, Refolo MG, et al:
Polyunsaturated fatty acids reduce fatty acid synthase and
hydroxy-methyl-glutaryl CoA-reductase gene expression and promote
apoptosis in HepG2 cell line. Lipids Health Dis. 10:102011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zecchin KG, Rossato FA, Raposo HF, et al:
Inhibition of fatty acid synthase in melanoma cells activates the
intrinsic pathway of apoptosis. Lab Invest. 91:232–240. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Carvalho MA, Zecchin KG, Seguin F, et al:
Fatty acid synthase inhibition with Orlistat promotes apoptosis and
reduces cell growth and lymph node metastasis in a mouse melanoma
model. Int J Cancer. 123:2557–2565. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Murata S, Yanagisawa K, Fukunaga K, et al:
Fatty acid synthase inhibitor cerulenin suppresses liver metastasis
of colon cancer in mice. Cancer Sci. 101:1861–1865. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang XX, Fu Z, Zhang Z, et al:
Microcystin-LR promotes melanoma cell invasion and enhances matrix
metalloproteinase-2/-9 expression mediated by nf-kappab activation.
Environ Sci Technol. 46:11319–11326. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kao SJ, Su JL, Chen CK, et al: Osthole
inhibits the invasive ability of human lung adenocarcinoma cells
via suppression of NF-kappaB-mediated matrix metalloproteinase-9
expression. Toxicol Appl Pharmacol. 261:105–115. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kuan YH, Huang FM, Li YC, et al:
Proinflammatory activation of macrophages by bisphenol
A-glycidyl-methacrylate involved NFkappaB activation via PI3K/Akt
pathway. Food Chem Toxicol. 50:4003–4009. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Swinnen JV, Van Veldhoven PP, Timmermans
L, et al: Fatty acid synthase drives the synthesis of phospholipids
partitioning into detergent-resistant membrane microdomains.
Biochem Biophys Res Commun. 302:898–903. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Uddin S, Siraj AK, Al-Rasheed M, et al:
Fatty acid synthase and AKT pathway signaling in a subset of
papillary thyroid cancers. J Clin Endocrinol Metab. 93:4088–4097.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang HQ, Altomare DA, Skele KL, et al:
Positive feedback regulation between AKT activation and fatty acid
synthase expression in ovarian carcinoma cells. Oncogene.
24:3574–3582. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Menendez JA, Vellon L, Mehmi I, et al:
Inhibition of fatty acid synthase (FAS) suppresses HER2/neu
(erbB-2) oncogene overexpression in cancer cells. Proc Natl Acad
Sci USA. 101:10715–10720. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bai X, Ma D, Liu A, et al: Rheb activates
mTOR by antagonizing its endogenous inhibitor, FKBP38. Science.
318:977–980. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li W, Tai Y, Zhou J, et al: Repression of
endometrial tumor growth by targeting SREBP1 and lipogenesis. Cell
Cycle. 11:2348–2358. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu ZL, Wang G, Shu Y, et al: Enhanced
antitumor activity of epirubicin combined with cerulenin in
osteosarcoma. Mol Med Report. 5:326–330. 2012.PubMed/NCBI
|
|
31
|
Bandyopadhyay S, Pai SK, Watabe M, et al:
FAS expression inversely correlates with PTEN level in prostate
cancer and a PI 3-kinase inhibitor synergizes with FAS siRNA to
induce apoptosis. Oncogene. 24:5389–5395. 2005. View Article : Google Scholar
|
|
32
|
Porstmann T, Griffiths B, Chung YL, et al:
PKB/Akt induces transcription of enzymes involved in cholesterol
and fatty acid biosynthesis via activation of SREBP. Oncogene.
24:6465–6481. 2005.PubMed/NCBI
|
|
33
|
Tomek K, Wagner R, Varga F, et al:
Blockade of fatty acid synthase induces ubiquitination and
degradation of phosphoinositide-3-kinase signaling proteins in
ovarian cancer. Mol Cancer Res. 9:1767–1779. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zaytseva YY, Rychahou PG, Gulhati P, et
al: Inhibition of fatty acid synthase attenuates CD44-associated
signaling and reduces metastasis in colorectal cancer. Cancer Res.
72:1504–1517. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Uddin S, Jehan Z, Ahmed M, et al:
Overexpression of fatty acid synthase in Middle Eastern epithelial
ovarian carcinoma activates AKT and Its inhibition potentiates
cisplatin-induced apoptosis. Mol Med. 17:635–645. 2011. View Article : Google Scholar
|
|
36
|
Andela VB, Gordon AH, Zotalis G, et al:
NFkappaB: a pivotal transcription factor in prostate cancer
metastasis to bone. Clin Orthop Relat Res. 415(Suppl): S75–S85.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Felx M, Guyot MC, Isler M, et al:
Endothelin-1 (ET-1) promotes MMP-2 and MMP-9 induction involving
the transcription factor NF-kappaB in human osteosarcoma. Clin Sci
(Lond). 110:645–654. 2006. View Article : Google Scholar : PubMed/NCBI
|
